Randomized, multicenter, open-labeled, two-arm parallel group trial of pitavastatin 2 mg OD for reducing the risk of major cardiovascular events in patients with clustering cardiovascular risk factors
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Pitavastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders
- Focus Therapeutic Use
Most Recent Events
- 14 Sep 2011 New trial record